In conclusion, we have proven that L-4F could inhibit pancreatic cancer progression, mostly by reducing the infiltration of PMN-MDSCs and weakening their immunosuppressive function by decreasing the phosphorylation of STAT3 in the tumor tissue. The gene discussed is STAT3; the disease is pancreatic neoplasm.